Mayo T, Armstrong A, Kircik L, Silverberg J, Blauvelt A, Esdaile B, Schneider S, Mark T, Gooderham M, Alexis A. Efficacy and safety of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.3];7(2):s141. Available from: https://jofskin.org/index.php/skin/article/view/2024